Valeant taps CEO Pearson as chairman; Asthma drug helps kids with milk allergies;

@FiercePharma: J&J chief hopes missing drugs return by year's end. News | Follow @FiercePharma

> Valeant Pharmaceuticals has appointed CEO Michael Pearson as chairman of the board and extended his contract until February 2017. Report

> Novartis and Roche's Xolair, a medication used to treat asthma attacks caused by allergens such as pollen and dust mites, helped children overcome milk allergies, a small study showed. News

> Pozen filed a motion to prevent generic drugmaker Par Pharmaceutical from launching a copycat version of its migraine drug Treximet. Story

> GW Pharmaceuticals' pioneering cannabis drug Sativex has been recommended for approval in the six other European countries targeted by the British company and Spanish partner Almirall. Item

> Lonza has been awarded two contracts for biological drug candidates in quick succession, including a new deal that will make use of its large-scale U.S. biopharmaceutical facility in New Hampshire. Article

> A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections. Story

Biotech News

@FierceBiotech: GSK's Witty: Development must be radically restructured in R&D revolution. Report | Follow @FierceBiotech

@JohnCFierce: Lilly's Lechleiter insists there will be no mega mergers for the 543rd time. Beijing report oddly misspells his name. Article | Follow @JohnCFierce

> Cephalon scoops up cancer drugs in $525M Gemin X buyout. News 

> Bristol's breakthrough melanoma drug delivers promising data in Ph3. Item 

> Peptimmune heads into bankruptcy after venture round fizzles. Article 

Biotech Research News

> Shar-pei DNA reveals new wrinkle in fever disorders. Article

> TB protein discovery could lead to better vax. News

> UK, UMass stem cell banks join forces. Story 

> Bluebird bio's gene therapy hits a high note. Report 

 Manufacturing News

> Little buzz for Obama's track/trace proposal. Item 

> Industry lobbies for foreign plant inspections. Article

> USP, FDA update quality standards for common drugs. Report 

> Genzyme: Fill/finish causes Thyrogen shortage. News

> Consent decree diminishes CEO Weldon's role in McNeil turnaround. Article 

> FDA, EMA team on QbD-based joint reviews. Story

And Finally... A new test for human papillomavirus is just as sensitive as the old one, but more specific for detecting cervical cancer, meaning that it has fewer false positive results. Report